{
    "index": 1660,
    "context": [
        "List of benzodiazepines\nDrug name | Common trade names | Year approved .mw-parser-output .nobold { font-weight : normal } ( US FDA ) | Time to peak onset of action ( hours ) | Elimination half-life of active metabolite ( hours ) | Therapeutic use\n--- | --- | --- | --- | --- | ---\nAdinazolam | Deracyn | Research chemical | 1-2 | 3 | anxiolytic , antidepressant\nAlprazolam | Xanax , Helex , Xanor , Trankimazin , Onax , Alprox , Misar , Restyl , Solanax , Tafil , Neurol , Frontin , Kalma , Ksalol | 1981 | 1-2 | 10-20 | anxiolytic , antidepressant\nBentazepam | Thiadipona |  | 1-3 | 2-4 | anxiolytic\nBretazenil |  |  |  | 2.5 | anxiolytic , anticonvulsant\nBromazepam | Lectopam , Lexaurin , Lexatin , Lexotanil , Lexotan , Bromam | 1981 | 1-3 | 20-40 | anxiolytic , hypnotic\nBromazolam |  | Research chemical |  |  | anxiolytic\nBrotizolam | Lendormin , Dormex , Sintonal , Noctilan |  | 0.5-2 | 4-5 | hypnotic\nCamazepam | Albego , Limpidon , Paxor |  | 0.5-2 | 6-29 | anxiolytic\nChlordiazepoxide | Librium , Risolid , Elenium | 1960 | 1.5-4 | 5-200 | anxiolytic\nCinazepam | Levana |  | 2-4 | 60 | hypnotic , anxiolytic\nCinolazepam | Gerodorm |  | 0.5-2 | 9 | hypnotic\nClobazam | Onfi , Frisium , Urbanol | 2011 | 1-3 | 8-60 | anxiolytic , anticonvulsant\nClonazepam | Rivatril , Rivotril , Klonopin , Iktorivil , Paxam | 1975 | 1-4 | 19.5-50 | anticonvulsant , anxiolytic , muscle relaxant\nClonazolam |  | Research chemical | 0.5-1.5 | 10-18 | anxiolytic , anticonvulsant , hypnotic , muscle relaxant\nClorazepate | Tranxene , Tranxilium | 1972 | Variable | 32-152 | anxiolytic , anticonvulsant\nClotiazepam | Veratran , Clozan , Rize |  | 1-3 | 4 | anxiolytic\nCloxazolam | Sepazon , Olcadil |  | 2-5 | 80-105 | anxiolytic , anticonvulsant\nDelorazepam | Dadumir |  | 1-2 | 80-105 | anxiolytic , amnesic\nDeschloroetizolam [ d ] [ lower-alpha 4 ] |  | Research chemical |  |  | anxiolytic\nDiazepam | Antenex , Apaurin , Apzepam , Apozepam , Diazepan , Hexalid , Normabel , Pax , Stesolid , Stedon , Tranquirit , Valium , Vival , Valaxona | 1963 | 1-1.5 | 32-205 | anxiolytic , anticonvulsant , muscle relaxant , amnesic\n\nwiki_section_title: Pharmacokinetic properties of various benzodiazepines\n\nwiki_section_text: Data in the table below is taken from the Ashton `` Benzodiazepine Equivalency Table '' . [ 4 ] [ 11 ] [ 12 ] [ 13 ]\n\nintro: The below tables contain a sample list of benzodiazepines and benzodiazepine analogs that are commonly prescribed, with their basic pharmacological characteristics, such as half-life and equivalent doses to other benzodiazepines, also listed, along with their trade names and primary uses. The elimination half-life is how long it takes for half of the drug to be eliminated by the body. Time to peak refers to when maximum levels of the drug in the blood occur after a given dose. Benzodiazepines generally share the same pharmacological properties, such as anxiolytic, sedative, hypnotic, skeletal muscle relaxant, amnesic, and anticonvulsant effects. Variation in potency of certain effects may exist amongst individual benzodiazepines. Some benzodiazepines produce active metabolites. Active metabolites are produced when a person's body metabolizes the drug into compounds that share a similar pharmacological profile to the parent compound and thus are relevant when calculating how long the pharmacological effects of a drug will last. Long-acting benzodiazepines with long-acting active metabolites, such as diazepam and chlordiazepoxide, are often prescribed for benzodiazepine or alcohol withdrawal as well as for anxiety if constant dose levels are required throughout the day. Shorter-acting benzodiazepines are often preferred for insomnia due to their lesser hangover effect. It is fairly important to note that elimination half-life of diazepam and chlordiazepoxide, as well as other long half-life benzodiazepines, is twice as long in the elderly compared to younger individuals. Individuals with an impaired liver also metabolize benzodiazepines more slowly. Many doctors[who?]\n\n"
    ],
    "qa": {
        "question": "What is the patent year of the Benzodiazepine medicine that has a 5–200 half life",
        "answer": "1958",
        "BM25_documents": [
            {
                "id": "nq_213721_40",
                "score": 15.682100296020508
            },
            {
                "id": "nq_67023_24",
                "score": 15.027099609375
            },
            {
                "id": "ott_12162_2",
                "score": 14.89490032196045
            },
            {
                "id": "ott_12492_2",
                "score": 14.894899368286133
            },
            {
                "id": "ott_14025_2",
                "score": 14.894898414611816
            },
            {
                "id": "ott_1660_2",
                "score": 14.8948974609375
            },
            {
                "id": "ott_12162_3",
                "score": 14.134099960327148
            },
            {
                "id": "ott_12492_3",
                "score": 14.134099006652832
            },
            {
                "id": "ott_14025_3",
                "score": 14.134098052978516
            },
            {
                "id": "ott_1660_3",
                "score": 14.1340970993042
            },
            {
                "id": "ott_12162_0",
                "score": 13.910799980163574
            },
            {
                "id": "ott_12492_0",
                "score": 13.910799026489258
            },
            {
                "id": "ott_14025_0",
                "score": 13.910798072814941
            },
            {
                "id": "ott_1660_0",
                "score": 13.910797119140625
            },
            {
                "id": "triviaqa_11456_11",
                "score": 13.421099662780762
            },
            {
                "id": "triviaqa_23111_8",
                "score": 13.288100242614746
            },
            {
                "id": "triviaqa_11456_12",
                "score": 12.682600021362305
            },
            {
                "id": "triviaqa_26118_89",
                "score": 12.668700218200684
            },
            {
                "id": "nq_93390_13",
                "score": 12.661499977111816
            },
            {
                "id": "nq_297897_11",
                "score": 12.639300346374512
            }
        ],
        "BM25_related_documents": [
            {
                "id": "ott_1660_2",
                "score": 14.8948974609375
            },
            {
                "id": "ott_1660_3",
                "score": 14.1340970993042
            },
            {
                "id": "ott_1660_0",
                "score": 13.910797119140625
            }
        ],
        "BM25_tat_documents": [
            {
                "id": "tat_753_0",
                "score": 10.288000106811523
            },
            {
                "id": "tat_535_0",
                "score": 9.930299758911133
            },
            {
                "id": "tat_753_1",
                "score": 9.716300010681152
            },
            {
                "id": "tat_1318_0",
                "score": 8.769700050354004
            },
            {
                "id": "tat_1695_0",
                "score": 7.462399959564209
            },
            {
                "id": "tat_1243_10",
                "score": 7.44189977645874
            },
            {
                "id": "tat_225_1",
                "score": 7.150400161743164
            },
            {
                "id": "tat_452_0",
                "score": 7.125800132751465
            },
            {
                "id": "tat_633_0",
                "score": 6.862100124359131
            },
            {
                "id": "tat_638_0",
                "score": 6.597899913787842
            }
        ],
        "BM25_ott_documents": [
            {
                "id": "ott_12162_2",
                "score": 14.89490032196045
            },
            {
                "id": "ott_12492_2",
                "score": 14.894899368286133
            },
            {
                "id": "ott_14025_2",
                "score": 14.894898414611816
            },
            {
                "id": "ott_1660_2",
                "score": 14.8948974609375
            },
            {
                "id": "ott_12162_3",
                "score": 14.134099960327148
            },
            {
                "id": "ott_12492_3",
                "score": 14.134099006652832
            },
            {
                "id": "ott_14025_3",
                "score": 14.134098052978516
            },
            {
                "id": "ott_1660_3",
                "score": 14.1340970993042
            },
            {
                "id": "ott_12162_0",
                "score": 13.910799980163574
            },
            {
                "id": "ott_12492_0",
                "score": 13.910799026489258
            }
        ],
        "BM25_nq_documents": [
            {
                "id": "nq_213721_40",
                "score": 15.682100296020508
            },
            {
                "id": "nq_67023_24",
                "score": 15.027099609375
            },
            {
                "id": "nq_93390_13",
                "score": 12.661499977111816
            },
            {
                "id": "nq_297897_11",
                "score": 12.639300346374512
            },
            {
                "id": "nq_213721_39",
                "score": 12.53499984741211
            },
            {
                "id": "nq_138031_3",
                "score": 12.297699928283691
            },
            {
                "id": "nq_138031_25",
                "score": 11.726799964904785
            },
            {
                "id": "nq_138031_4",
                "score": 11.629899978637695
            },
            {
                "id": "nq_253445_42",
                "score": 11.440299987792969
            },
            {
                "id": "nq_244566_2",
                "score": 11.39229965209961
            }
        ],
        "BM25_triviaqa_documents": [
            {
                "id": "triviaqa_11456_11",
                "score": 13.421099662780762
            },
            {
                "id": "triviaqa_23111_8",
                "score": 13.288100242614746
            },
            {
                "id": "triviaqa_11456_12",
                "score": 12.682600021362305
            },
            {
                "id": "triviaqa_26118_89",
                "score": 12.668700218200684
            },
            {
                "id": "triviaqa_11456_10",
                "score": 12.383600234985352
            },
            {
                "id": "triviaqa_70741_34",
                "score": 12.065899848937988
            },
            {
                "id": "triviaqa_40236_27",
                "score": 11.790300369262695
            },
            {
                "id": "triviaqa_40236_26",
                "score": 11.548999786376953
            },
            {
                "id": "triviaqa_67086_47",
                "score": 11.484600067138672
            },
            {
                "id": "triviaqa_67086_48",
                "score": 11.415300369262695
            }
        ],
        "BM25_kg_documents": [
            {
                "id": "m.081k8_3018",
                "score": 8.977399826049805
            },
            {
                "id": "m.01cx__422",
                "score": 8.535893440246582
            },
            {
                "id": "m.0hkf_30",
                "score": 8.119799613952637
            },
            {
                "id": "m.06mt91_391",
                "score": 7.89139986038208
            },
            {
                "id": "m.06mt91_82",
                "score": 7.891398906707764
            },
            {
                "id": "m.013mbz_58",
                "score": 7.683899879455566
            },
            {
                "id": "m.0d1b__11",
                "score": 7.554900169372559
            },
            {
                "id": "m.01crd5_829",
                "score": 7.534900188446045
            },
            {
                "id": "m.01vrvd_8",
                "score": 7.520799160003662
            },
            {
                "id": "m.06_rf9_179",
                "score": 7.504799842834473
            },
            {
                "id": "m.0djn04_17",
                "score": 7.47160005569458
            },
            {
                "id": "m.07pzc_453",
                "score": 7.428400039672852
            },
            {
                "id": "m.0gzh_257",
                "score": 7.4029998779296875
            },
            {
                "id": "m.03n2qq_1",
                "score": 7.389599800109863
            },
            {
                "id": "m.04glrxj_35",
                "score": 7.31820011138916
            },
            {
                "id": "m.015fr_6627",
                "score": 7.276299953460693
            },
            {
                "id": "m.013yrz_29",
                "score": 7.2664971351623535
            },
            {
                "id": "m.0l8mh7y_9",
                "score": 7.259799957275391
            },
            {
                "id": "m.04lt7__167",
                "score": 7.2565999031066895
            },
            {
                "id": "m.0gzh_1154",
                "score": 7.253699779510498
            }
        ],
        "BGE_documents": [
            {
                "id": "ott_12492_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_14025_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_12162_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_1660_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_12162_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_12492_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_1660_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_14025_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_1660_0",
                "score": 0.7080972790718079
            },
            {
                "id": "ott_12162_0",
                "score": 0.7080972790718079
            },
            {
                "id": "ott_12492_0",
                "score": 0.7080972790718079
            },
            {
                "id": "ott_14025_0",
                "score": 0.7080972790718079
            },
            {
                "id": "ott_14025_1",
                "score": 0.689782977104187
            },
            {
                "id": "ott_12492_1",
                "score": 0.689782977104187
            },
            {
                "id": "ott_12162_1",
                "score": 0.689782977104187
            },
            {
                "id": "ott_1660_1",
                "score": 0.689782977104187
            },
            {
                "id": "triviaqa_11456_11",
                "score": 0.6778691411018372
            },
            {
                "id": "nq_138031_23",
                "score": 0.6762807965278625
            },
            {
                "id": "nq_81534_237",
                "score": 0.6762466430664062
            },
            {
                "id": "nq_254736_157",
                "score": 0.6748226284980774
            }
        ],
        "BGE_related_documents": [
            {
                "id": "ott_1660_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_1660_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_1660_0",
                "score": 0.7080972790718079
            },
            {
                "id": "ott_1660_1",
                "score": 0.689782977104187
            }
        ],
        "BGE_tat_documents": [],
        "BGE_ott_documents": [
            {
                "id": "ott_12492_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_14025_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_12162_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_1660_3",
                "score": 0.7281282544136047
            },
            {
                "id": "ott_12162_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_12492_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_1660_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_14025_2",
                "score": 0.7258008122444153
            },
            {
                "id": "ott_1660_0",
                "score": 0.7080972790718079
            },
            {
                "id": "ott_12162_0",
                "score": 0.7080972790718079
            }
        ],
        "BGE_nq_documents": [
            {
                "id": "nq_138031_23",
                "score": 0.6762807965278625
            },
            {
                "id": "nq_81534_237",
                "score": 0.6762466430664062
            },
            {
                "id": "nq_254736_157",
                "score": 0.6748226284980774
            },
            {
                "id": "nq_218409_440",
                "score": 0.6747370958328247
            },
            {
                "id": "nq_138031_41",
                "score": 0.6734979152679443
            },
            {
                "id": "nq_185124_25",
                "score": 0.6714525818824768
            },
            {
                "id": "nq_18439_188",
                "score": 0.6703532934188843
            },
            {
                "id": "nq_254736_374",
                "score": 0.6694258451461792
            },
            {
                "id": "nq_222405_1",
                "score": 0.6691787242889404
            },
            {
                "id": "nq_81534_398",
                "score": 0.669119656085968
            }
        ],
        "BGE_triviaqa_documents": [
            {
                "id": "triviaqa_11456_11",
                "score": 0.6778691411018372
            },
            {
                "id": "triviaqa_11456_12",
                "score": 0.6631315350532532
            },
            {
                "id": "triviaqa_60132_21",
                "score": 0.6528233289718628
            },
            {
                "id": "triviaqa_11456_17",
                "score": 0.6480748653411865
            },
            {
                "id": "triviaqa_23053_37",
                "score": 0.6463373899459839
            },
            {
                "id": "triviaqa_66314_9",
                "score": 0.6371321678161621
            },
            {
                "id": "triviaqa_26118_139",
                "score": 0.6369627714157104
            },
            {
                "id": "triviaqa_74353_38",
                "score": 0.6317046284675598
            },
            {
                "id": "triviaqa_11456_18",
                "score": 0.6296182870864868
            },
            {
                "id": "triviaqa_32666_183",
                "score": 0.6285955309867859
            }
        ],
        "BGE_kg_documents": [
            {
                "id": "m.0hqqqnh_6",
                "score": 0.6483219265937805
            },
            {
                "id": "m.0hqqqnh_5",
                "score": 0.6479942202568054
            },
            {
                "id": "m.0hqqqnh_7",
                "score": 0.6454825401306152
            },
            {
                "id": "m.0hqqqnh_1",
                "score": 0.6427067518234253
            },
            {
                "id": "m.0hqlgrb_8",
                "score": 0.6408501863479614
            },
            {
                "id": "m.0hqqqnh_4",
                "score": 0.6406630277633667
            },
            {
                "id": "m.02qvz_4065",
                "score": 0.6391825675964355
            },
            {
                "id": "m.0hqlgrb_9",
                "score": 0.636858344078064
            },
            {
                "id": "m.0hqlgrb_7",
                "score": 0.6351320743560791
            },
            {
                "id": "m.0hqqqnh_3",
                "score": 0.6343304514884949
            },
            {
                "id": "m.02qvz_107",
                "score": 0.632195770740509
            },
            {
                "id": "m.054yc0_194",
                "score": 0.6319074034690857
            },
            {
                "id": "m.0hqlgrb_3",
                "score": 0.6316571831703186
            },
            {
                "id": "m.0hqlgrb_4",
                "score": 0.6311006546020508
            },
            {
                "id": "m.0hqqqnh_0",
                "score": 0.630683183670044
            },
            {
                "id": "m.01tf_6_43",
                "score": 0.6271420121192932
            },
            {
                "id": "m.04g9r_95",
                "score": 0.626151442527771
            },
            {
                "id": "m.04g9r_88",
                "score": 0.6260379552841187
            },
            {
                "id": "m.0hqqqnh_2",
                "score": 0.6253873109817505
            },
            {
                "id": "m.04306rv_7462",
                "score": 0.6248688101768494
            }
        ],
        "llm_mark_result": {
            "ott_1660_0": {
                "Query Analysis": "The query seeks the patent year of a benzodiazepine medication that has an elimination half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the specific benzodiazepine.",
                "Document Content Analysis": "The document lists various benzodiazepines, including their common trade names, year approved by the US FDA, time to peak onset of action, elimination half-life of active metabolite, and therapeutic uses.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and includes information on 'elimination half-life'.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention the year 1958.",
                "Key Information Matching": "The document provides elimination half-life data for various benzodiazepines, including one that matches the 5–200 hour range (Chlordiazepoxide).",
                "Can the Document Answer the Query": "No, the document does not directly state the patent year of the benzodiazepine with a 5–200 hour half-life.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document helps identify the specific benzodiazepine (Chlordiazepoxide) that has the required half-life, but it does not provide its patent year.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it helps identify the specific benzodiazepine with the required half-life, but it lacks the specific information needed to directly answer the query about the patent year."
            },
            "ott_12492_2": {
                "Query Analysis": "The query seeks the patent year of a specific benzodiazepine medicine that has a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the benzodiazepine in question.",
                "Document Content Analysis": "The document provides a table listing various benzodiazepines, their trade names, patent years, half-lives, and primary uses. It also includes an introductory section explaining the pharmacokinetic properties of benzodiazepines.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepine' and includes data on 'half-life'.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention '1958'.",
                "Key Information Matching": "The document contains information about the half-lives of various benzodiazepines but does not directly match the specific half-life range of 5–200 hours or the patent year 1958.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year for a benzodiazepine with a half-life of 5–200 hours.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides general information about benzodiazepines and their pharmacokinetic properties, which could be useful for understanding the context of the query.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it contains information about benzodiazepines and their half-lives, which are key aspects of the query. However, it lacks the specific details needed to directly answer the query about the patent year of a benzodiazepine with a half-life of 5–200 hours."
            },
            "m.01cx__422": {
                "Query Analysis": "The query seeks the year in which the patent for a specific Benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer indicates that the patent year for the specified Benzodiazepine medicine is 1958.",
                "Document Content Analysis": "The document lists various books and their places of publication, all being Boston. It does not contain any information related to pharmaceuticals, medicines, or patents.",
                "Document and Query Keywords Matching": "None of the query keywords (patent year, Benzodiazepine, medicine, 5–200 half life) are found in the document.",
                "Document and Answer Keywords Matching": "The document does not contain the keyword '1958' or any related context.",
                "Key Information Matching": "There is no matching key information between the query, answer, and the document content.",
                "Can the Document Answer the Query": "No, the document does not contain any information related to the query.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document provides no relevant context or additional information that could help infer the answer to the query.",
                "Relevance Judgement": "0",
                "Explanation": "The document is entirely unrelated to the query. It focuses on the publication details of various books in Boston, while the query pertains to the patent year of a specific type of medicine. There is no overlap in subject matter, keywords, or relevant context."
            },
            "ott_14025_2": {
                "Query Analysis": "The query seeks the patent year of a specific benzodiazepine medicine that has a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the specific benzodiazepine.",
                "Document Content Analysis": "The document provides a table listing various benzodiazepines, their trade names, patent years, half-lives, and primary uses. It also includes an introductory section explaining the pharmacokinetic properties of benzodiazepines.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine', 'half-life', and includes specific half-life values.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention '1958'.",
                "Key Information Matching": "The document contains information about various benzodiazepines, their half-lives, and patent years, which are key to answering the query.",
                "Can the Document Answer the Query": "No, the document does not directly specify a benzodiazepine with a half-life of 5–200 hours and its patent year.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides a list of benzodiazepines with their half-lives and patent years, which could help in identifying the specific medicine if more information were available.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it contains information about benzodiazepines, their half-lives, and patent years. However, it does not directly match the specific half-life range (5–200 hours) and patent year (1958) required by the query. It provides useful context but lacks the specific detail needed to directly answer the query."
            },
            "ott_12492_3": {
                "Query Analysis": "The query seeks the year in which the patent for a specific benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the year the patent was granted for the specified benzodiazepine medicine.",
                "Document Content Analysis": "The document provides general information about benzodiazepines, including their pharmacological properties, uses, and factors affecting their elimination half-life. It mentions specific benzodiazepines like diazepam and chlordiazepoxide and discusses how half-lives vary, especially in different populations.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and discusses 'half-life', but does not explicitly mention the range '5–200' or 'patent year'.",
                "Document and Answer Keywords Matching": "The document does not mention the year '1958' or any specific patent years.",
                "Key Information Matching": "While the document provides information about benzodiazepines and their half-lives, it lacks specific details about the patent year or a benzodiazepine with a half-life of 5–200 hours.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any specific benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "Partially, the document offers general knowledge about benzodiazepines and their half-lives, which could be useful background information but does not directly help infer the specific patent year.",
                "Relevance Judgement": "1",
                "Explanation": "The document is somewhat related to the query as it discusses benzodiazepines and their half-lives, which are key components of the query. However, it lacks specific details about the patent year or a benzodiazepine with the exact half-life range mentioned in the query, making it partially relevant."
            },
            "m.081k8_3018": {
                "Query Analysis": "The query asks for the year in which the patent for a specific Benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, indicating the year the patent was granted for the specified medicine.",
                "Document Content Analysis": "The document provides information related to William Shakespeare, including his works, influences, and awards. It primarily focuses on his literary contributions and various quotes from his plays.",
                "Document and Query Keywords Matching": "None of the query keywords (patent year, Benzodiazepine, medicine, 5–200 half life) are found in the document.",
                "Document and Answer Keywords Matching": "The document does not mention the year 1958 or any context related to patents or medicines.",
                "Key Information Matching": "There is no key information in the document that matches or is related to the query or the answer.",
                "Can the Document Answer the Query": "No, the document does not contain any information about Benzodiazepine medicines or their patent years.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document provides no relevant context or additional information that could help infer the answer to the query.",
                "Relevance Judgement": "0",
                "Explanation": "The document is entirely unrelated to the query. It focuses exclusively on William Shakespeare and his literary works, which have no connection to the topic of Benzodiazepine medicines or their patent years. Therefore, it is deemed irrelevant."
            },
            "m.0hqqqnh_6": {
                "Query Analysis": "The query is seeking the year in which the patent for a specific Benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer indicates that the patent year for the specified Benzodiazepine medicine is 1958.",
                "Document Content Analysis": "The document primarily focuses on Alprazolam 0.5 tablet, detailing various sections related to its clinical studies, adverse reactions, overdosage, description, indications and usage, dosage and administration, contraindications, drug abuse and dependence, and manufactured forms. It does not provide specific information about the patent year or the half-life of the drug.",
                "Document and Query Keywords Matching": "The document mentions 'Alprazolam', which is a Benzodiazepine, but does not contain the other keywords such as 'patent year' or 'half life 5–200'.",
                "Document and Answer Keywords Matching": "The document does not mention the year '1958' or any other year related to the patent.",
                "Key Information Matching": "While the document discusses a Benzodiazepine (Alprazolam), it lacks the specific details about its patent year and half-life.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year or the half-life information required to answer the query directly.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not offer any contextual information that could help infer the patent year or the half-life of the specified Benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document is focused on Alprazolam and its various clinical and usage aspects but does not provide any information about its patent year or half-life. Therefore, it is irrelevant to the query as it neither answers the query directly nor aids in inferring the required information."
            },
            "ott_12162_3": {
                "Query Analysis": "The query seeks the year in which a specific benzodiazepine medicine, characterized by a half-life ranging from 5 to 200 hours, was patented.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer indicates that the patent year of the specified benzodiazepine is 1958.",
                "Document Content Analysis": "The document discusses general properties of benzodiazepines, including their pharmacological effects, types based on half-life, and factors affecting metabolism. It mentions specific long-acting benzodiazepines like diazepam and chlordiazepoxide but does not provide their patent years.",
                "Document and Query Keywords Matching": "The document includes the keyword 'Benzodiazepine' and discusses 'half-life', but does not mention 'patent year' or the specific range '5–200'.",
                "Document and Answer Keywords Matching": "The document does not contain the keyword '1958'.",
                "Key Information Matching": "While the document discusses benzodiazepines and their half-lives, it lacks specific information about the patent year or the exact half-life range mentioned in the query.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any specific benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides general information about benzodiazepines and their half-lives, which could be useful for understanding the context but not for answering the specific query.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it discusses benzodiazepines and their half-lives, which are related to the query. However, it lacks the specific details needed to directly answer the query about the patent year of a benzodiazepine with a 5–200 hour half-life."
            },
            "nq_213721_40": {
                "Query Analysis": "The query seeks the year in which a specific benzodiazepine medicine, characterized by a half-life ranging from 5 to 200 hours, was patented.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the year the benzodiazepine medicine was patented.",
                "Document Content Analysis": "The document discusses the liver's role in breaking down toxic substances, the impact of aging on the liver's oxidative capacity, and the accumulation of medications like benzodiazepines. It mentions specific benzodiazepines such as lorazepam and oxazepam, which have shorter half-lives, and their preference in geriatric medicine.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines' and 'half-lives', which are relevant keywords from the query.",
                "Document and Answer Keywords Matching": "The document does not mention the year '1958' or any specific patent year.",
                "Key Information Matching": "While the document discusses benzodiazepines and their half-lives, it does not provide any information about the patent year of any specific benzodiazepine.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not offer any context or additional information that could help infer the patent year of the specified benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document is irrelevant to the query as it does not provide any information about the patent year of benzodiazepine medicines. While it mentions benzodiazepines and their half-lives, these details do not assist in answering the specific query about the patent year."
            },
            "tat_753_0": {
                "Query Analysis": "The query seeks the year in which a specific Benzodiazepine medicine with a half-life ranging from 5 to 200 hours was patented.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer indicates that the patent year of the specified Benzodiazepine medicine is 1958.",
                "Document Content Analysis": "The document provides financial data related to intangible assets, including patents, for the years 2019 and 2018. It details the cost, amortization, and other financial aspects of various intangible assets, including patents acquired from different sources. The document also mentions the useful life of issued patents and the amortization periods for different types of intangible assets.",
                "Document and Query Keywords Matching": "The document mentions 'patents' but does not reference 'Benzodiazepine', 'half life', or any specific years related to the patenting of a medicine.",
                "Document and Answer Keywords Matching": "The document does not mention the year '1958' or any specific years related to the patenting of a medicine.",
                "Key Information Matching": "There is no direct or indirect mention of Benzodiazepine, its half-life, or its patent year in the document. The document focuses on financial and amortization details of patents in general.",
                "Can the Document Answer the Query": "No, the document does not provide any information about the patent year of a specific Benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not contain any relevant information that could help infer the patent year or any details about Benzodiazepine medicines.",
                "Relevance Judgement": "0",
                "Explanation": "The document is entirely focused on financial data and amortization details of intangible assets, including patents, but does not provide any specific information about the patenting of Benzodiazepine medicines or their half-lives. Therefore, it is irrelevant to the query."
            },
            "triviaqa_11456_11": {
                "Query Analysis": "The query seeks the year in which the patent for a specific benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the year when the patent for the specified benzodiazepine medicine was granted.",
                "Document Content Analysis": "The document discusses the FDA's review and findings on the combined use of opioid medicines with benzodiazepines or other CNS depressants, highlighting serious side effects and regulatory actions such as adding Boxed Warnings to drug labeling. It provides background on the uses of opioids and benzodiazepines and recommendations for healthcare professionals.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines' but does not reference 'patent year', 'half life', or the specific range '5–200'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific years related to benzodiazepine patents.",
                "Key Information Matching": "While the document discusses benzodiazepines in the context of their uses and regulatory concerns, it lacks any information about the patent year or half-life of specific benzodiazepine medications.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year or specific details about the half-life of any benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not offer any relevant details that could help infer the patent year or half-life of the specified benzodiazepine medicine.",
                "Relevance Judgement": "0",
                "Explanation": "The document is focused on regulatory actions and safety concerns related to the combined use of opioids and benzodiazepines, but it does not contain any information about the patent year or half-life of specific benzodiazepine medications. Therefore, it is irrelevant to the query."
            },
            "nq_67023_24": {
                "Query Analysis": "The query seeks the patent year of a specific Benzodiazepine medicine characterized by a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the year the Benzodiazepine medicine was patented.",
                "Document Content Analysis": "The document discusses radioactive substances, their half-lives, and their historical use in patent medicines. It mentions elements with varying half-lives and the biological effects of radiation, including the misuse of radioactive substances in medicinal treatments.",
                "Document and Query Keywords Matching": "The document mentions 'patent medicines' but does not reference 'Benzodiazepine', 'half life', or '5–200'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific years related to patenting of medicines.",
                "Key Information Matching": "There is no direct or indirect mention of Benzodiazepines, their half-lives, or their patent years in the document.",
                "Can the Document Answer the Query": "No, the document does not provide any information about Benzodiazepines or their patent years.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document's focus on radioactive substances and their historical use in patent medicines does not aid in inferring information about Benzodiazepines.",
                "Relevance Judgement": "0",
                "Explanation": "The document is entirely unrelated to the query. It discusses radioactive substances and their historical use in patent medicines, which is not relevant to the specific query about the patent year of a Benzodiazepine medicine with a certain half-life. Therefore, it provides no useful context or additional information pertinent to the query."
            },
            "ott_1660_3": {
                "Query Analysis": "The query seeks the year in which a specific benzodiazepine medicine with a half-life ranging from 5 to 200 hours was patented.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the benzodiazepine in question.",
                "Document Content Analysis": "The document provides general information about benzodiazepines, including their pharmacological properties, types (long-acting and shorter-acting), and factors affecting their elimination half-life. It mentions specific benzodiazepines like diazepam and chlordiazepoxide and discusses their uses and effects on different populations.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepines' and discusses 'elimination half-life', but does not specify a range of 5–200 hours.",
                "Document and Answer Keywords Matching": "The document does not mention the year '1958' or any specific patent year.",
                "Key Information Matching": "While the document discusses benzodiazepines and their half-lives, it does not provide specific half-life ranges or patent years for any benzodiazepine.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any specific benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document lacks specific details about the half-life range and patent year of any benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document, while informative about benzodiazepines in general, does not contain specific information about the patent year or the half-life range of 5–200 hours for any benzodiazepine. Therefore, it is irrelevant to the query as it neither answers the query directly nor provides useful context to infer the answer."
            },
            "nq_138031_23": {
                "Query Analysis": "The query asks for the year in which the patent for a specific benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the specific benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the effects, uses, and side effects of benzodiazepines. It mentions their use in treating generalized anxiety disorder (GAD), potential for dependence, and various side effects like drowsiness and impaired motor coordination. It also lists some popular benzodiazepines but does not provide any information about their patent years or half-lives.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepines' but does not include 'patent year', 'half life', or '5–200'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific years related to patents.",
                "Key Information Matching": "The document provides general information about benzodiazepines but lacks specific details about their patent years or half-lives.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year or half-life information for any benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not contain any information that could help infer the patent year or half-life of benzodiazepines.",
                "Relevance Judgement": "0",
                "Explanation": "The document is not relevant to the query as it does not provide any specific information about the patent year or half-life of benzodiazepine medicines. It only discusses general uses, effects, and side effects of benzodiazepines, which do not assist in answering the query."
            },
            "m.0hqqqnh_5": {
                "Query Analysis": "The query is seeking the year in which the patent for a specific Benzodiazepine medicine with a half-life ranging from 5 to 200 hours was granted.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer indicates that the patent year for the specified Benzodiazepine medicine is 1958.",
                "Document Content Analysis": "The document provides detailed information about Alprazolam 0.5 tablet, including various sections of its label such as indications and usage, package label, how supplied, clinical studies, warnings, animal pharmacology/toxicology, adverse reactions, and overdosage. It also mentions the flavor of the drug and categorizes it as a consumer product and non-agent.",
                "Document and Query Keywords Matching": "The document mentions 'Alprazolam', which is a Benzodiazepine, but does not explicitly mention 'patent year' or 'half life'.",
                "Document and Answer Keywords Matching": "The document does not contain the keyword '1958' or any direct reference to the patent year.",
                "Key Information Matching": "While the document discusses a Benzodiazepine medication (Alprazolam), it lacks any information about its patent year or half-life.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year or the half-life of Alprazolam.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not offer any contextual information that could help infer the patent year or half-life of the medication.",
                "Relevance Judgement": "0",
                "Explanation": "The document is focused on specific label information and general details about Alprazolam 0.5 tablet but does not address the key aspects of the query, which are the patent year and the half-life of the medication. Therefore, it is irrelevant to the query."
            },
            "ott_14025_3": {
                "Query Analysis": "The query seeks the patent year of a specific benzodiazepine medicine characterized by a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the year the patent for the relevant benzodiazepine medicine was granted.",
                "Document Content Analysis": "The document discusses general properties of benzodiazepines, including their pharmacological effects, types based on half-life (long-acting and shorter-acting), and factors affecting metabolism. It mentions specific long-acting benzodiazepines like diazepam and chlordiazepoxide but does not provide their patent years.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and discusses 'half-life', aligning with two key terms from the query.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific patent years.",
                "Key Information Matching": "While the document discusses benzodiazepines and their half-lives, it does not provide specific information about the patent year of any benzodiazepine.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any specific benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides general information about benzodiazepines and their half-lives, which could be useful for understanding the context but not for answering the specific query about the patent year.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it discusses benzodiazepines and their half-lives, which are key terms in the query. However, it lacks specific information about the patent year, making it unable to directly answer the query. The document provides useful context but does not contain the critical detail required to fully address the query."
            },
            "ott_12162_2": {
                "Query Analysis": "The query seeks the patent year of a specific benzodiazepine medicine characterized by a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the relevant benzodiazepine.",
                "Document Content Analysis": "The document provides a table listing various benzodiazepines, their trade names, patent years, half-lives, and primary uses. It also includes an introductory section explaining the pharmacokinetic properties of benzodiazepines.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine', 'half-life', and includes specific half-life values.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention '1958'.",
                "Key Information Matching": "The document provides detailed information about various benzodiazepines, including their half-lives, but does not directly match the 5–200 half-life range or the patent year 1958.",
                "Can the Document Answer the Query": "No, the document does not specify a benzodiazepine with a 5–200 half-life and its corresponding patent year.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides a list of benzodiazepines with their half-lives and patent years, which could help in identifying the relevant medicine if more specific information were available.",
                "Relevance Judgement": "1",
                "Explanation": "The document contains relevant information about benzodiazepines, including their half-lives and patent years, but lacks the specific details needed to directly answer the query. It can, however, provide useful context for understanding the pharmacokinetic properties of benzodiazepines."
            },
            "ott_1660_2": {
                "Query Analysis": "The query seeks the patent year of a specific benzodiazepine medicine that has a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, benzodiazepine, half life, 5–200",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the benzodiazepine in question.",
                "Document Content Analysis": "The document provides a table listing various benzodiazepines, their trade names, patent years, half-lives, and primary uses. It also includes an introductory section explaining general pharmacological properties of benzodiazepines.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines' and includes data on 'half-life', which are directly relevant to the query.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention the year '1958'.",
                "Key Information Matching": "The document contains information about the half-lives of various benzodiazepines, which is a key aspect of the query. However, it does not directly provide the patent year of a benzodiazepine with a half-life of 5–200 hours.",
                "Can the Document Answer the Query": "No, the document does not directly provide the patent year of a benzodiazepine with the specified half-life range.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides detailed information about the half-lives and patent years of various benzodiazepines, which could help in identifying the specific medicine if more context were provided.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it contains information about benzodiazepines and their half-lives, which are key components of the query. However, it lacks the specific detail (patent year of a benzodiazepine with a 5–200 hour half-life) needed to directly answer the query."
            }
        },
        "llm_mark_result_ds": {
            "ott_1660_0": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine with the specified half-life.",
                "Document Content Analysis": "The document provides a list of Benzodiazepines, including their drug names, common trade names, year approved by the US FDA, time to peak onset of action, elimination half-life of active metabolite, and therapeutic use.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life'.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention the year 1958.",
                "Key Information Matching": "The document lists Chlordiazepoxide, which has an elimination half-life of 5–200 hours, matching the query's requirement. However, the document does not specify the patent year but mentions the year approved by the US FDA, which is 1960 for Chlordiazepoxide.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of the Benzodiazepine medicine with a 5–200 half-life.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document identifies Chlordiazepoxide as a Benzodiazepine with a half-life of 5–200 hours, which is relevant to the query. However, it does not provide the patent year but mentions the year approved by the US FDA (1960).",
                "Relevance Judgement": "1",
                "Explanation": "The document contains relevant information about Benzodiazepines and identifies a drug with the specified half-life, but it does not provide the exact patent year requested in the query. It offers partial relevance by helping to identify the drug but lacks the specific detail needed to answer the query directly."
            },
            "ott_12492_2": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine in question.",
                "Document Content Analysis": "The document provides a list of benzodiazepines, including their trade names, pharmacological characteristics (such as half-life), and patent years. It also includes a section on the pharmacokinetic properties of benzodiazepines, explaining terms like half-life and active metabolites.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life', which are key terms from the query.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention '1958', the patent year provided in the answer.",
                "Key Information Matching": "The document lists several benzodiazepines with their half-lives and patent years, but none of them have a half-life in the range of 5–200 hours. The closest match is Diazepam, which has a half-life of 32-205 hours and a patent year of 1963, but this does not match the answer provided (1958).",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of a Benzodiazepine with a half-life of 5–200 hours.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides information about the half-lives and patent years of various benzodiazepines, which could help infer the patent year of a Benzodiazepine with a specific half-life.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant because it provides information about benzodiazepines, including their half-lives and patent years, which are related to the query. However, it does not directly answer the query or provide the specific patent year (1958) for a Benzodiazepine with a half-life of 5–200 hours."
            },
            "m.01cx__422": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document lists various publications and their places of publication, all of which are in Boston. There is no mention of Benzodiazepine, medicine, patents, or half-life.",
                "Document and Query Keywords Matching": "None of the query keywords ('patent year', 'Benzodiazepine', 'medicine', '5–200 half life') are found in the document.",
                "Document and Answer Keywords Matching": "The answer keyword '1958' is not found in the document.",
                "Key Information Matching": "The document does not contain any information related to Benzodiazepine, medicine, patents, or half-life.",
                "Can the Document Answer the Query": "No, the document does not contain any information about Benzodiazepine or its patent year.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any relevant information that could help infer the patent year or any details about Benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document is entirely unrelated to the query. It does not mention Benzodiazepine, medicine, patents, or half-life, nor does it provide any context or information that could assist in answering the query. Therefore, it is irrelevant."
            },
            "ott_14025_2": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine being referred to.",
                "Document Content Analysis": "The document provides a list of benzodiazepines, including their trade names, patent years, half-lives, and primary uses. It also includes a section on the pharmacokinetic properties of benzodiazepines, explaining terms like half-life and active metabolites.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life', which are keywords from the query.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention '1958', the patent year in the answer.",
                "Key Information Matching": "The document lists several benzodiazepines with their patent years and half-lives, but none of them have a half-life in the range of 5–200 hours. The closest match is Diazepam, which has a half-life of 32–205 hours and a patent year of 1963.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of a Benzodiazepine with a half-life of 5–200 hours.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides information about the patent years and half-lives of various benzodiazepines, which could help infer the answer or narrow down the search.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant because it provides information about benzodiazepines, including their patent years and half-lives, but it does not directly answer the query. It could help infer additional information, but it lacks the specific details needed to fully answer the query."
            },
            "ott_12492_3": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the pharmacological properties of Benzodiazepines, including their elimination half-life, active metabolites, and uses. It mentions specific Benzodiazepines like diazepam and chlordiazepoxide, their half-lives, and their effects on different populations.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepines' and 'half-life', which are relevant to the query.",
                "Document and Answer Keywords Matching": "The document does not mention the patent year 1958 or any specific patent-related information.",
                "Key Information Matching": "The document provides information about Benzodiazepines and their half-lives but does not mention the patent year or any specific patent-related details.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any Benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not contain any information that could help infer the patent year of the Benzodiazepine medicine.",
                "Relevance Judgement": "0",
                "Explanation": "The document discusses Benzodiazepines and their pharmacological properties, including half-life, but it does not provide any information about the patent year of any Benzodiazepine medicine. Therefore, it is irrelevant to the query."
            },
            "m.081k8_3018": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document contains information about William Shakespeare, including his works, influences, and awards. There is no mention of Benzodiazepine, medicine, or any related terms.",
                "Document and Query Keywords Matching": "None of the query keywords ('patent year', 'Benzodiazepine', 'medicine', '5–200 half-life') are found in the document.",
                "Document and Answer Keywords Matching": "The answer keyword '1958' is not found in the document.",
                "Key Information Matching": "The document does not contain any information related to Benzodiazepine, medicine, or patent years.",
                "Can the Document Answer the Query": "No, the document does not contain any information about Benzodiazepine or its patent year.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any relevant information to infer the patent year or any details about Benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document is entirely unrelated to the query. It discusses William Shakespeare and his works, with no mention of Benzodiazepine, medicine, or patent years. Therefore, it is irrelevant to the query."
            },
            "m.0hqqqnh_6": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document provides information about Alprazolam 0.5 tablet, including its sections like 'Clinical Studies', 'Adverse Reactions', 'Overdosage', 'Description', 'Indications And Usage', 'Dosage And Administration', 'Contraindications', and 'Drug Abuse And Dependence'. However, it does not mention the patent year or the half-life of the drug.",
                "Document and Query Keywords Matching": "The document mentions 'Alprazolam', which is a Benzodiazepine, but it does not mention 'patent year' or '5–200 half-life'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any patent year.",
                "Key Information Matching": "The document does not provide any information about the patent year or the half-life of the Benzodiazepine medicine.",
                "Can the Document Answer the Query": "No, the document does not contain the patent year of the Benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year or the half-life of the Benzodiazepine medicine.",
                "Relevance Judgement": "0",
                "Explanation": "The document is about Alprazolam, a Benzodiazepine, but it does not provide any information about the patent year or the half-life of the drug. Therefore, it is irrelevant to the query."
            },
            "ott_12162_3": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the pharmacological properties of Benzodiazepines, including their elimination half-life, active metabolites, and uses. It mentions specific Benzodiazepines like diazepam and chlordiazepoxide, their half-lives, and their relevance in medical treatment. However, it does not mention the patent year of any Benzodiazepine.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life', which are keywords from the query.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any patent year related to Benzodiazepines.",
                "Key Information Matching": "The document provides information about Benzodiazepines, including their half-lives and pharmacological properties, but it does not mention the patent year of any Benzodiazepine.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of any Benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year of the Benzodiazepine medicine.",
                "Relevance Judgement": "0",
                "Explanation": "The document discusses Benzodiazepines and their pharmacological properties, including half-life, but it does not provide any information about the patent year of any Benzodiazepine. Therefore, it is irrelevant to the query."
            },
            "nq_213721_40": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the liver's role in metabolizing medications, specifically mentioning benzodiazepines and their half-lives. It also mentions that medications with shorter half-lives, such as lorazepam and oxazepam, are preferred in geriatric medicine.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines' and 'half-lives', which are relevant to the query.",
                "Document and Answer Keywords Matching": "The document does not mention the patent year '1958' or any specific patent-related information.",
                "Key Information Matching": "The document provides information about benzodiazepines and their half-lives but does not mention the patent year or any specific details about the patent.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of the Benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year or any related details.",
                "Relevance Judgement": "0",
                "Explanation": "The document mentions benzodiazepines and their half-lives, which are related to the query, but it does not provide any information about the patent year or any details that could help infer the answer. Therefore, the document is irrelevant to the query."
            },
            "tat_753_0": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, indicating the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses intangible assets, including patents, their acquisition, amortization, and write-offs. It mentions patents acquired from STI and GVR, their useful lives, and amortization periods. However, it does not specifically mention Benzodiazepine or its patent year.",
                "Document and Query Keywords Matching": "The document mentions 'patents' and 'amortization', which are related to the query's keyword 'patent year'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific patent year related to Benzodiazepine.",
                "Key Information Matching": "The document provides general information about patents and their amortization but does not contain specific details about Benzodiazepine or its patent year.",
                "Can the Document Answer the Query": "No, the document does not mention Benzodiazepine or its patent year.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year of Benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document discusses patents and their amortization but does not mention Benzodiazepine or its patent year. It provides no relevant information to answer the query or infer additional details. Therefore, it is irrelevant to the query."
            },
            "triviaqa_11456_11": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the FDA's review of the combined use of opioids and benzodiazepines, their side effects, and recommendations for prescribing these drugs. It provides background information on benzodiazepines, including their uses for anxiety, insomnia, and seizures, but does not mention any specific patent years or half-lives of benzodiazepines.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines', which matches the query keyword 'Benzodiazepine'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific patent years.",
                "Key Information Matching": "The document does not provide any information about the patent year or half-life of benzodiazepines, which are the key elements of the query.",
                "Can the Document Answer the Query": "No, the document does not mention the patent year or half-life of benzodiazepines.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year or half-life of benzodiazepines.",
                "Relevance Judgement": "0",
                "Explanation": "The document is irrelevant to the query because it does not provide any information about the patent year or half-life of benzodiazepines. It focuses on the combined use of opioids and benzodiazepines and their side effects, which is unrelated to the specific information requested in the query."
            },
            "nq_67023_24": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses radioactive substances, their half-lives, and their use in patent medicines. It mentions the marketing of radioactive substances as patent medicines and the dangers associated with them. However, it does not mention Benzodiazepines or their patent years.",
                "Document and Query Keywords Matching": "The document mentions 'patent medicines' and 'half-life', but does not mention 'Benzodiazepine' or '5–200 half life'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific patent year related to Benzodiazepines.",
                "Key Information Matching": "The document does not provide any information about Benzodiazepines or their patent years. It focuses on radioactive substances and their use in patent medicines.",
                "Can the Document Answer the Query": "No, the document does not contain any information about Benzodiazepines or their patent years.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any relevant information that could help infer the patent year of Benzodiazepines.",
                "Relevance Judgement": "0",
                "Explanation": "The document is irrelevant to the query as it does not mention Benzodiazepines, their patent years, or any information that could help infer the answer. It focuses on radioactive substances and their use in patent medicines, which is unrelated to the query."
            },
            "ott_1660_3": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the pharmacological properties of Benzodiazepines, including their half-life, active metabolites, and uses. It mentions specific Benzodiazepines like diazepam and chlordiazepoxide, their elimination half-life, and their relevance in medical treatment. However, it does not mention the patent year of any Benzodiazepine.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life', but it does not specify a half-life range of 5–200 hours or mention the patent year.",
                "Document and Answer Keywords Matching": "The document does not mention the year 1958 or any patent-related information.",
                "Key Information Matching": "The document provides information about Benzodiazepines and their half-life but lacks any mention of the patent year or a specific half-life range of 5–200 hours.",
                "Can the Document Answer the Query": "No, the document does not mention the patent year of any Benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year or the specific half-life range mentioned in the query.",
                "Relevance Judgement": "0",
                "Explanation": "The document discusses Benzodiazepines and their pharmacological properties, but it does not contain any information about the patent year or the specific half-life range mentioned in the query. Therefore, it is irrelevant to the query."
            },
            "nq_138031_23": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document discusses the effects, uses, and side effects of Benzodiazepines, including their short-term benefits and long-term drawbacks. It mentions specific Benzodiazepines like alprazolam, lorazepam, and clonazepam but does not provide information about the patent year or half-life of any Benzodiazepine.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepines' and 'medicine' but does not mention 'patent year' or '5–200 half-life'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any specific patent year.",
                "Key Information Matching": "The document does not provide any information about the patent year or half-life of Benzodiazepines, which are key to answering the query.",
                "Can the Document Answer the Query": "No, the document does not mention the patent year or half-life of any Benzodiazepine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year or half-life of a Benzodiazepine.",
                "Relevance Judgement": "0",
                "Explanation": "The document discusses Benzodiazepines and their effects but does not contain any information about the patent year or half-life of any Benzodiazepine. Therefore, it is irrelevant to the query."
            },
            "m.0hqqqnh_5": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document provides detailed information about Alprazolam 0.5 tablet, including its label sections, warnings, clinical studies, and other related details. However, it does not mention the patent year or the half-life of Benzodiazepine medicines.",
                "Document and Query Keywords Matching": "The document does not mention 'Benzodiazepine', 'patent year', or '5–200 half-life'.",
                "Document and Answer Keywords Matching": "The document does not mention '1958' or any patent year related to Benzodiazepine.",
                "Key Information Matching": "The document does not provide any key information related to the query, such as the patent year or half-life of Benzodiazepine medicines.",
                "Can the Document Answer the Query": "No, the document does not contain the patent year of the Benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year or half-life of Benzodiazepine medicines.",
                "Relevance Judgement": "0",
                "Explanation": "The document is irrelevant to the query as it does not provide any information about the patent year or half-life of Benzodiazepine medicines. It focuses solely on Alprazolam 0.5 tablet, which is not directly related to the query."
            },
            "ott_14025_3": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine.",
                "Document Content Analysis": "The document provides detailed information about Benzodiazepines, including their pharmacological properties, elimination half-life, active metabolites, and their uses. However, it does not mention any specific patent years or the exact half-life range of 5–200 hours.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepines' and 'elimination half-life', but it does not specify the range of 5–200 hours or any patent years.",
                "Document and Answer Keywords Matching": "The document does not mention the year 1958 or any patent-related information.",
                "Key Information Matching": "The document discusses Benzodiazepines and their half-life but does not provide the specific half-life range (5–200 hours) or the patent year (1958) mentioned in the query and answer.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of the Benzodiazepine medicine with a 5–200 half-life.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not contain any information that could help infer the patent year or the specific half-life range.",
                "Relevance Judgement": "0",
                "Explanation": "The document is not relevant to the query as it does not provide any information about the patent year of the Benzodiazepine medicine or the specific half-life range of 5–200 hours. It focuses on general pharmacological properties and uses of Benzodiazepines but lacks the key details required to answer the query."
            },
            "ott_12162_2": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine in question.",
                "Document Content Analysis": "The document provides a list of benzodiazepines, including their trade names, pharmacological characteristics (such as half-life), and primary uses. It also mentions the patent year for some benzodiazepines, such as Diazepam, which has a patent year of 1963.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life', which are key terms from the query.",
                "Document and Answer Keywords Matching": "The document does not mention the year 1958, which is the answer to the query.",
                "Key Information Matching": "The document provides information about benzodiazepines, including their half-lives and patent years, but it does not specify a benzodiazepine with a half-life of 5–200 hours or the patent year 1958.",
                "Can the Document Answer the Query": "No, the document does not contain the specific patent year (1958) for a benzodiazepine with a half-life of 5–200 hours.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, the document provides general information about benzodiazepines, including their half-lives and patent years, which could help in understanding the context of the query.",
                "Relevance Judgement": "1",
                "Explanation": "The document is partially relevant as it provides information about benzodiazepines, including their half-lives and patent years, but it does not directly answer the query or provide the specific patent year (1958) for a benzodiazepine with a half-life of 5–200 hours."
            },
            "ott_1660_2": {
                "Query Analysis": "The query asks for the patent year of a Benzodiazepine medicine that has a half-life of 5–200 hours.",
                "Query Keywords Extraction": "patent year, Benzodiazepine, medicine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958, which is the patent year of the Benzodiazepine medicine in question.",
                "Document Content Analysis": "The document provides a list of benzodiazepines, including their trade names, patent years, half-lives, and primary uses. It also includes a section on the pharmacokinetic properties of benzodiazepines, explaining terms like half-life and active metabolites.",
                "Document and Query Keywords Matching": "The document mentions 'Benzodiazepine' and 'half-life', which are key terms from the query.",
                "Document and Answer Keywords Matching": "The document does not explicitly mention '1958', the patent year provided in the answer.",
                "Key Information Matching": "The document lists several benzodiazepines with their patent years and half-lives, but none of them have a half-life in the range of 5–200 hours. The closest match is Diazepam, which has a half-life of 32-205 hours and a patent year of 1963, but this does not match the query's requirement of a 5–200 half-life and the answer of 1958.",
                "Can the Document Answer the Query": "No, the document does not provide the patent year of a Benzodiazepine with a 5–200 half-life.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document does not provide any information that could help infer the patent year of a Benzodiazepine with a 5–200 half-life.",
                "Relevance Judgement": "0",
                "Explanation": "The document does not contain the specific information required by the query, nor does it provide any relevant context or additional information that could help infer the answer. Therefore, it is deemed irrelevant."
            }
        },
        "llm_mark_result_gpt": {
            "ott_1660_0": {},
            "ott_12492_2": {},
            "m.01cx__422": {},
            "ott_14025_2": {},
            "ott_12492_3": {
                "Query Analysis": "The query asks for the patent year of a specific benzodiazepine medicine characterized by a 5–200 hour elimination half-life.",
                "Query Keywords Extraction": "patent year, Benzodiazepine medicine, 5–200 half-life",
                "Answer Analysis": "The answer indicates the patent year as 1958.",
                "Document Content Analysis": "The document elaborates on the pharmacological properties of benzodiazepines, including their effects, variations in potency, and elimination half-life. It also mentions specific benzodiazepines like diazepam and chlordiazepoxide, detailing their half-life and the factors affecting it.",
                "Document and Query Keywords Matching": "The document addresses 'benzodiazepines' and discusses 'elimination half-life', but does not match the specific half-life range of 5–200 or 'patent year'.",
                "Document and Answer Keywords Matching": "The document does not mention the year 1958.",
                "Key Information Matching": "The document provides background on benzodiazepines and their half-life characteristics, but does not include historical data like the patent year or specifics for the 5–200 hour half-life category.",
                "Can the Document Answer the Query": "No, the document lacks historical data regarding patent years.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, while it provides information on benzodiazepines, it does not connect to the patent year or specifically to the given elimination half-life range.",
                "Relevance Judgement": "0",
                "Explanation": "The document offers general insights into the pharmacology of benzodiazepines but does not touch on historical patent data or the specific elimination half-life range mentioned in the query. Therefore, it cannot directly answer the query or provide related inferences."
            },
            "m.081k8_3018": {},
            "m.0hqqqnh_6": {},
            "ott_12162_3": {
                "Query Analysis": "The query asks for the patent year of a benzodiazepine medicine that has a half-life range of 5 to 200 hours.",
                "Query Keywords Extraction": "benzodiazepine, patent year, 5–200 half-life",
                "Answer Analysis": "The answer provided is the patent year, 1958.",
                "Document Content Analysis": "The document discusses benzodiazepines in general, including their pharmacological properties, elimination half-life, use of active metabolites, and considerations for use in certain populations. Specific benzodiazepines like diazepam and chlordiazepoxide are mentioned, but there is no mention of patent years.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines' and 'half-life', which are part of the query.",
                "Document and Answer Keywords Matching": "The document does not mention the answer, '1958', and contains no patent-related information.",
                "Key Information Matching": "The document provides general information about benzodiazepines and their half-lives but does not address the query's specific request for the patent year.",
                "Can the Document Answer the Query": "No, the document does not specify the patent year of any benzodiazepine medicine.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document provides information on the pharmacological properties and half-lives of benzodiazepines, but it does not provide any indirect information that could help infer the patent year.",
                "Relevance Judgement": "0",
                "Explanation": "The document contains general information about benzodiazepines, focusing on pharmacological effects and half-life details, but it does not address or provide any information relevant to the patent year of benzodiazepines. Therefore, it is considered irrelevant to the query."
            },
            "nq_213721_40": {},
            "tat_753_0": {},
            "triviaqa_11456_11": {},
            "nq_67023_24": {},
            "ott_1660_3": {},
            "nq_138031_23": {},
            "m.0hqqqnh_5": {},
            "ott_14025_3": {
                "Query Analysis": "The query requests the patent year of a benzodiazepine medicine that has a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, benzodiazepine, 5–200 half-life",
                "Answer Analysis": "The answer is 1958.",
                "Document Content Analysis": "The document provides an overview of benzodiazepines, their pharmacological properties, application, and differences among them, particularly in terms of half-life and their effects on different populations.",
                "Document and Query Keywords Matching": "The document mentions 'benzodiazepines' and discusses 'half-life', relevant to the query but does not provide specifics about the 5–200 half-life range or patent year.",
                "Document and Answer Keywords Matching": "The document does not mention the patent year '1958'.",
                "Key Information Matching": "While the document discusses benzodiazepines and half-life, it lacks specific information about patents or the exact half-life range of 5–200 hours.",
                "Can the Document Answer the Query": "No, the document does not provide information on patent years of benzodiazepine medicines.",
                "Can the Document Help Infer Additional Information Required by the Query": "No, the document lacks relevant patent information or specifics about the half-life required by the query.",
                "Relevance Judgement": "0",
                "Explanation": "The document provides general information about benzodiazepines, but it does not contain specific details about the patent year or specific half-life ranges. It is irrelevant to the query as it neither answers the query nor aids in inferring the answer."
            },
            "ott_12162_2": {},
            "ott_1660_2": {
                "Query Analysis": "The query seeks the patent year of a specific benzodiazepine medicine characterized by a half-life ranging from 5 to 200 hours.",
                "Query Keywords Extraction": "patent year, benzodiazepine, 5–200 half life",
                "Answer Analysis": "The patent year provided for the required benzodiazepine is 1958.",
                "Document Content Analysis": "The document offers pharmacokinetic data about various benzodiazepines, including their trade names, half-lives, patent years, and primary uses. Diazepam's patent year is listed as 1963, with a half-life between 32-205 hours.",
                "Document and Query Keywords Matching": "The document discusses benzodiazepines and half-life, which are key elements of the query.",
                "Document and Answer Keywords Matching": "The document mentions patent years but does not list 1958, hence no direct match with the answer.",
                "Key Information Matching": "The document provides half-life information for several benzodiazepines, including one (Diazepam) with a half-life that fits the 5-200 range, but not the exact patent year required.",
                "Can the Document Answer the Query": "No, the document does not provide a patent year of 1958 for a benzodiazepine with a half-life of 5–200 that matches the query.",
                "Can the Document Help Infer Additional Information Required by the Query": "Yes, it includes half-life details and other pharmacokinetic properties that could be useful for identifying specific benzodiazepines matching particular criteria.",
                "Relevance Judgement": "1",
                "Explanation": "While the document provides relevant information about benzodiazepines, including half-lives and some patent years, it does not directly answer the query about a patent year of 1958. It offers useful context about benzodiazepines generally, contributing information that could aid further research, thus warranting a partially relevant judgement."
            }
        },
        "relevance_judgement": 1,
        "llm_fail": {},
        "dataset_score": {
            "triviaqa": 0,
            "tat": 0,
            "ott": 4,
            "nq": 0,
            "kg": 0
        }
    }
}